scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1051312367 |
P356 | DOI | 10.1186/S12943-015-0369-2 |
P932 | PMC publication ID | 4431032 |
P698 | PubMed publication ID | 25971982 |
P5875 | ResearchGate publication ID | 276308856 |
P2093 | author name string | Seung Won Shin | |
Joo Young Lee | |||
Jung Eun Koo | |||
Soong Ho Um | |||
P2860 | cites work | The effects of TLR activation on T-cell development and differentiation | Q27001581 |
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 | ||
Interferons at age 50: past, current and future impact on biomedicine | Q28259312 | ||
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors | Q29615665 | ||
Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells | Q30179408 | ||
Enzyme-catalysed assembly of DNA hydrogel. | Q51129307 | ||
Malignancy after renal transplantation | Q77440701 | ||
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides | Q81474815 | ||
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance | Q30436506 | ||
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. | Q33211563 | ||
Human tumor xenograft models for preclinical assessment of anticancer drug development | Q33554319 | ||
Akt Contributes to Activation of the TRIF-Dependent Signaling Pathways of TLRs by Interacting with TANK-Binding Kinase 1 | Q34151749 | ||
The spontaneous regression of cancer. A review of cases from 1900 to 1987. | Q34230803 | ||
Intracellular invasion of Orientia tsutsugamushi activates inflammasome in asc-dependent manner | Q34314100 | ||
Intrinsic and extrinsic regulation of innate immune receptors | Q35003295 | ||
Immunotherapeutic uses of CpG oligodeoxynucleotides | Q35730784 | ||
Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2. | Q36757009 | ||
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer | Q37050998 | ||
The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. | Q37144338 | ||
Immune therapy for cancer | Q37324793 | ||
Strange attractors: DAMPs and autophagy link tumor cell death and immunity | Q37424115 | ||
Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids | Q37664915 | ||
Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells | Q39002621 | ||
PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells | Q39017204 | ||
Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice | Q39646708 | ||
Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice | Q39795607 | ||
Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation | Q40020895 | ||
Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides | Q40376314 | ||
TLR9 signals after translocating from the ER to CpG DNA in the lysosome | Q40600429 | ||
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients | Q41940744 | ||
Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor | Q45165652 | ||
Identification and distribution of the costimulatory receptor CD28 in the mouse | Q46503670 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | toll-like receptor | Q408004 |
inflammasome complex | Q412405 | ||
colon cancer | Q18555025 | ||
P304 | page(s) | 104 | |
P577 | publication date | 2015-05-15 | |
P1433 | published in | Molecular Cancer | Q15724585 |
P1476 | title | X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes | |
P478 | volume | 14 |
Q37596126 | CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies |
Q89736145 | DNA Nanostructure as an Efficient Drug Delivery Platform for Immunotherapy |
Q49531599 | Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities |
Q88727565 | Elucidation of the Mechanism of Increased Activity of Immunostimulatory DNA by the Formation of Polypod-like Structure |
Q92427012 | Hybrid material of structural DNA with inorganic compound: synthesis, applications, and perspective |
Q97526934 | Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression |
Q56594845 | Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics |